Le 11 novembre 2005 - LES BIOTECHNOLOGIES OSTA INC. réalise un placement privé de 150 000 $ (.pdf)

Le 4 novembre 2005 - LES BIOTECHNOLOGIES OSTA INC. annonce des résultats prometteurs issus de sa seconde étude clinique visant le développement d'une nouvelle analyse sanguine pour l'ostéoporose (.pdf)

Les communiqués de presse suivants ne sont disponibles qu'en anglais.

October 4, 2005 - OSTA BIOTECHNOLOGIES INC. announces a breakthrough discovery in aging and cancer research (.pdf)

September 27, 2005 - OSTA BIOTECHNOLOGIES INC. announces significant findings in a study of human PTH (1-34) in its mouse model for osteoporosis (.pdf)

June 6,   2005 - BIOPOTENTIAL CAPITAL INC. announces the Appointment of Dr. Thomas J. Hudson to its Scientific Advisory Board (.pdf)

May 3, 2005 - BIOPOTENTIAL CAPITAL announces closing of qualifying transaction with OSTA BIOPHARMA (.pdf)

April 5, 2005 - BIOPOTENTIAL CAPITAL INC. announces conditional acceptance of its proposed qualifying transaction with OSTA BIOPHARMA INC. (.pdf)

March 22, 2005 - BIOPOTENTIAL CAPITAL INC. announces signing of a licensing agreement for a novel Alzheimer's diagnostic technology by OSTA BIOPHARMA INC. (.pdf)

February 14, 2005 - BIOPOTENTIAL CAPITAL INC. announces signing of share exchange agreement with OSTA BIOPHARMA INC. (.pdf)

August 20, 2004 - BIOPOTENTIAL CAPITAL INC. announces proposed qualifying transaction with OSTA BIOPHARMA INC. (.pdf)